Trulieve Cannabis Corp C.TRUL

Alternate Symbol(s): C.TRUL.NT.U | TCNNF

Healthcare

Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company has established cannabis operations in three hubs: Southeast, Northeast, and Southwest. Its three regional hubs are anchored by market positions in cornerstone states of Florida, Pennsylvania, and Arizona. The Company operates in regulated markets that require knowledge in cultivation, manufacturing, and retail. The Company utilizes various extraction techniques, including critical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, the Company owns and utilizes carbon dioxide extraction, distillation, purification and manufacturing technology that is used to produce a range of cannabis topicals and vapes featuring cannabinoids. The Company's brands include premium tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, Roll One, and Trekkers.

CSE:TRUL - Post by User

Trulieve Cannabis Corp

Bullboard Posts

Comment by dload7on Oct 09, 2018 10:12am

71 Views

Post# 28765591

RE:RE:Why Trulieve will break 30$ very soon

TheAdvisor.FRWM wrote: Cramer is effectivly a key trigger in mass visibility. For the story,I had 4 friend with deep pocket (10 millions holding +) who called/texted me this morning so they recommended me to load on Trulieve, after the heard about it yesterday for the first time ...

To complete your article, I would just say that, on top of it, legalization (700% upside) or allowance of dried flower (200% upside) would raize the revenues / price target forecast by a lot.

I believe it's an important key point to consider, since theses twos even could double to 7x the adressable market of Trulieve (in FLorida only).

Thanks

Multibagger6950 wrote: ***PLEASE NOTE JIM CRAMER interviewed Trulieve CEO yesterday on MADMONEY***

Hi board, I've been there since day1 and will not sell a single share below 43.50$/shares

What are the key trigger this week for the massive surge already started

1) Judge issued a limitation of new licence (blocked new licenses) in Florida last week, therefore consolidating Trulieve dominant player in Florida

2) Company has been exposed on CNBC with Jim Cramer, (and if you follow Cramer, he very rarely invite new company like Trulieve, unless there is a tremendous potential and serious intention to buy the stock)

3) The company stated with Cramer (Kim Rivers,ceo) there are looking to expand in the very short term -in others states

4) Florida Health Departement released 170 000 patients (and around 2400 new patient / week), with Trulieve having more than 120 000 of them.

5) Last quarter, Trulieve filled they 23.3 millions US revenues with 80 000 patients. If you do the math, they will have around 34.95 US millions revenues +- in Q3, which is more than 46 millions CAD of Revenues expected for Q3 and around 30 millions NET PROFIT CAD for Q3 (this is beating CANOPY forecast in Q2 2019 with recretionnal priced in...)

6) GMP has a price target of 43.50$ CAD, Cannacord has a price target of 24$ US with potential upside up to 57$.

7) Serious technical and day trader suggested the low float and the high volume combined with the fundamentals could make this a Tilray #2

8) The company has the highest revenues and the highest net profit of all the marijuana space. Company has a cash position with more than 100 millions USD in their warchest

9 ) Finally, the Florida medical market is expected to tripple up in 2019 and double up in 2020

10) When point #9 will occur, Trulieve will have 300 millions revenues in 2019 (150 millions EBITDA) and 575 millions revenues in 2020 (250 millions USD net profit), which will make this (without any expansion interstate) a 75-100$/stock a share (in 2020) - can you imagine his shareprice?

Bye